Oct 13, 2016
By Donald Macarthur, Pharmaceutical Executive, Volume 36, Issue 10
The revision of pricing rules that occurs every two years in Japan, with a new list of reimbursement prices simultaneously appearing, is not normally something to get too excited about. In the Japanese manner, change is characterized by evolution not revolution, and then only after lengthy discussion and the development of a wide-spread consensus. Read more.....